In pancreatic cancer, longer survival is observed in patients with tumours that are efficiently infiltrated by CD8+ T-cells, FoxP3+ and NK cells, and carry higher volumes of neo-antigens [145]. The gene discussed is CD8A; the disease is neoplasm.